Based on research at KU Leuven, Ghent University and VIB, Aphea.Bio is working on a product that can increase crop yield while protecting against fungal diseases.
Aphea.Bio, a Belgium-based biopesticides spinout of VIB, KU Leuven and Ghent University, raised €7.7m ($8.7m) in a series A round on Monday from investors including VIB itself.
The round was led by V-Bio Ventures, an investment fund affiliated with VIB, and included Qbic II, a €40m multi-university venturing fund that invests in spinouts from Ghent University, the universities of Antwerp and Brussels, as well as research organisation Vito.
The Gemma Frisius Fund KU Leuven, a seed-stage vehicle aimed at…
